Bartolozzi; Alessandra
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bartolozzi; Alessandra.The latest application filed is for "pharmacokinetically improved compounds".
Company Profile
3.34.26
- Bartolozzi; Alessandra - Somerville MA
- Bartolozzi; Alessandra - Norwalk CT
Patent Activity
| Patent | Date |
|---|---|
| Pharmacokinetically Improved Compounds App 20210017166 - Bartolozzi; Alessandra ; et al. | 2021-01-21 |
| Inhibitors Of Microbially Induced Amyloid App 20200290970 - Campbell; Anthony Stewart ; et al. | 2020-09-17 |
| Pharmacokinetically improved compounds Grant 10,570,123 - Bartolozzi , et al. Feb | 2020-02-25 |
| Pharmacokinetically Improved Compounds App 20190177311 - Bartolozzi; Alessandra ; et al. | 2019-06-13 |
| Pharmacokinetically Improved Compounds App 20180072710 - Bartolozzi; Alessandra ; et al. | 2018-03-15 |
| Inhibitors of microsomal triglyceride transfer protein and apo-B secretion Grant 9,656,960 - Bartolozzi , et al. May 23, 2 | 2017-05-23 |
| Rho-kinase inhibitors and method of preparation Grant 9,440,961 - Bartolozzi , et al. September 13, 2 | 2016-09-13 |
| Compounds which modulate the CB2 receptor Grant 9,315,454 - Bartolozzi , et al. April 19, 2 | 2016-04-19 |
| Inhibitors Of Microsomal Triglyceride Transfer Protein And Apo-b Secretion App 20160039765 - Bartolozzi; Alessandra ; et al. | 2016-02-11 |
| Pharmacokinetically Improved Compounds App 20150344464 - BARTOLOZZI; ALESSANDRA ; et al. | 2015-12-03 |
| Heterocyclic compounds as inhibitors of leukotriene production Grant 9,174,980 - Bartolozzi , et al. November 3, 2 | 2015-11-03 |
| Inhibitors of microsomal triglyceride transfer protein and apo-B secretion Grant 8,980,915 - Bartolozzi , et al. March 17, 2 | 2015-03-17 |
| Pharmacokinetically improved compounds Grant 8,916,576 - Bartolozzi , et al. December 23, 2 | 2014-12-23 |
| Heterocyclic compounds which modulate the CB2 receptor Grant 8,889,670 - Bartolozzi , et al. November 18, 2 | 2014-11-18 |
| Compounds which selectively modulate the CB2 receptor Grant 8,735,430 - Bartolozzi , et al. May 27, 2 | 2014-05-27 |
| Oxadiazole inhibitors of leukotriene production Grant 8,658,661 - Bartolozzi , et al. February 25, 2 | 2014-02-25 |
| Oxadiazole inhibitors of leukotriene production Grant 8,580,829 - Bartolozzi , et al. November 12, 2 | 2013-11-12 |
| Oxadiazole inhibitors of leukotriene production Grant 8,580,825 - Bartolozzi , et al. November 12, 2 | 2013-11-12 |
| Oxadiazole inhibitors of leukotriene production Grant 8,575,201 - Bartolozzi , et al. November 5, 2 | 2013-11-05 |
| Heterocyclic Compounds As Inhibitors Of Leukotriene Production App 20130196967 - BARTOLOZZI; Alessandra ; et al. | 2013-08-01 |
| Pharmacokinetically Improved Compounds App 20130131047 - BARTOLOZZI; ALESSANDRA ; et al. | 2013-05-23 |
| Compounds which selectively modulate the CB2 receptor Grant 8,383,651 - Bartolozzi , et al. February 26, 2 | 2013-02-26 |
| Compounds which selectively modulate the CB2 receptor Grant 8,372,874 - Bartolozzi , et al. February 12, 2 | 2013-02-12 |
| Compounds Which Selectively Modulate The CB2 Receptor App 20130030022 - BARTOLOZZI; Alessandra ; et al. | 2013-01-31 |
| Therapeutic uses of compounds which selectively modulate the CB2 receptor Grant 8,362,039 - Bartolozzi , et al. January 29, 2 | 2013-01-29 |
| Pharmacokinetically improved compounds Grant 8,357,693 - Bartolozzi , et al. January 22, 2 | 2013-01-22 |
| Therapeutic uses of compounds which selectively modulate the CB2 receptor Grant 8,349,871 - Bartolozzi , et al. January 8, 2 | 2013-01-08 |
| Compounds Which Modulate The Cb2 Receptor App 20120316173 - Bartolozzi; Alessandra ; et al. | 2012-12-13 |
| Oxadiazole Inhibitors Of Leukotriene Production App 20120295896 - BARTOLOZZI; Alessandra ; et al. | 2012-11-22 |
| Compounds which selectively modulate the CB2 receptor Grant 8,299,103 - Bartolozzi , et al. October 30, 2 | 2012-10-30 |
| Oxadiazole Inhibitors Of Leukotriene Production App 20120245162 - BARTOLOZZI; Alessandra ; et al. | 2012-09-27 |
| Oxadiazole Inhibitors Of Leukotriene Production App 20120220561 - BARTOLOZZI; Alessandra ; et al. | 2012-08-30 |
| Oxadiazole Inhibitors Of Leukotriene Production App 20120214787 - BARTOLOZZI; Alessandra ; et al. | 2012-08-23 |
| Rho Kinase Inhibitors App 20120202793 - Sweetnam; Paul ; et al. | 2012-08-09 |
| Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor App 20120010184 - BARTOLOZZI; Alessandra ; et al. | 2012-01-12 |
| Heterocyclic Compounds Which Modulate The CB2 Receptor App 20110312944 - Bartolozzi; Alessandra ; et al. | 2011-12-22 |
| Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor App 20110312932 - BARTOLOZZI; Alessandra ; et al. | 2011-12-22 |
| Compounds which selectively modulate the CB2 receptor Grant 8,048,899 - Bartolozzi , et al. November 1, 2 | 2011-11-01 |
| Compounds Which Selectively Modulate The CB2 Receptor App 20110136869 - Bartolozzi; Alessandra ; et al. | 2011-06-09 |
| Compounds Which Selectively Modulate The CB2 Receptor App 20110071196 - BARTOLOZZI; Alessandra ; et al. | 2011-03-24 |
| Pharmacokinetically improved compounds App 20100144707 - Bartolozzi; Alessandra ; et al. | 2010-06-10 |
| Compounds Which Selectively Modulate The CB2 Receptor App 20100081644 - BARTOLOZZI; Alessandra ; et al. | 2010-04-01 |
| Compounds Which Selectively Modulate The CB2 Receptor App 20100076029 - BARTOLOZZI; Alessandra ; et al. | 2010-03-25 |
| Inhibitors of microsomal triglyceride transfer protein and apo-B secretion App 20070027183 - Bartolozzi; Alessandra ; et al. | 2007-02-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 